FDA To Assess Gaps Between Drug Review And Product Label Content
This article was originally published in The Tan Sheet
Executive Summary
FDA will evaluate drug review documents and approved product labeling for gaps in information as part of a quality assurance effort for drug reviews in the Center for Drug Evaluation & Research.